Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease

NCT00225173 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Disease

Interventions

DRUG: Doxorubicin
DRUG: Vinblastine
DRUG: Cyclophosphamide
DRUG: Etoposide
DRUG: Vincristine
DRUG: Bleomycin
DRUG: Gemcitabine
DRUG: Vinorelbine
DRUG: Prednisone

Sponsor

Stanford University

Collaborators

[object Object]